Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Prevalence and prognostic significance of myeloid markers in adults with high-risk acute lymphoblastic leukemia].
Plensa E, Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández Ribas JM, Moreno MJ, del Potro E, Tormo M, Rivas C, Besalduch J, Sanz MA, Arias J, Fernández Calvo J, Moraleda JM, Bueno J, Feliu E, Ortega JJ; Grupo PETHEMA. Plensa E, et al. Among authors: sanz ma. Med Clin (Barc). 2005 Sep 3;125(7):241-6. doi: 10.1157/13078098. Med Clin (Barc). 2005. PMID: 16137483 Spanish.
Acute promyelocytic leukemia. Therapy results and prognostic factors.
Sanz MA, Jarque I, Martín G, Lorenzo I, Martínez J, Rafecas J, Pastor E, Sayas MJ, Sanz G, Gomis F. Sanz MA, et al. Among authors: sanz g. Cancer. 1988 Jan 1;61(1):7-13. doi: 10.1002/1097-0142(19880101)61:1<7::aid-cncr2820610103>3.0.co;2-6. Cancer. 1988. PMID: 3422032
Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.
Montserrat E, Alcalá A, Parody R, Domingo A, García-Conde J, Bueno J, Ferrán C, Sanz MA, Giralt M, Rubio D, et al. Montserrat E, et al. Among authors: sanz ma. Cancer. 1985 Nov 15;56(10):2369-75. doi: 10.1002/1097-0142(19851115)56:10<2369::aid-cncr2820561004>3.0.co;2-n. Cancer. 1985. PMID: 3899346 Clinical Trial.
A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.
Sanz MA, Martín G, Rayón C, Esteve J, González M, Díaz-Mediavilla J, Bolufer P, Barragán E, Terol MJ, González JD, Colomer D, Chillón C, Rivas C, Gómez T, Ribera JM, Bornstein R, Román J, Calasanz MJ, Arias J, Alvarez C, Ramos F, Debén G. Sanz MA, et al. Blood. 1999 Nov 1;94(9):3015-21. Blood. 1999. PMID: 10556184 Free article. Clinical Trial.
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.
Sanz MA, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, Díaz-Mediavilla J, Fioritoni G, González JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzalez M, Rodeghiero F, Colomer D, Petti MC, Ribera JM, Mandelli F. Sanz MA, et al. Blood. 2000 Aug 15;96(4):1247-53. Blood. 2000. PMID: 10942364 Free article. Clinical Trial.
575 results